The role of inflammatory mediators in epilepsy: Focus on developmental and epileptic encephalopathies and therapeutic implications

Alessandro Orsini, Thomas Foiadelli, Giorgio Costagliola, Alexandre Michev, Rita Consolini, Federica Vinci, Diego Peroni, Pasquale Striano, Salvatore Savasta

Research output: Contribution to journalReview articlepeer-review

Abstract

In recent years, there has been an increasing interest in the potential involvement of neuroinflammation in the pathogenesis of epilepsy. Specifically, the role of innate immunity (that includes cytokines and chemokines) has been extensively investigated either in animal models of epilepsy and in clinical settings. Developmental and epileptic encephalopathies (DEE) are a heterogeneous group of epileptic disorders, in which uncontrolled epileptic activity results in cognitive, motor and behavioral impairment. By definition, epilepsy in DEE is poorly controlled by common antiepileptic drugs but may respond to alternative treatments, including steroids and immunomodulatory drugs. In this review, we will focus on how cytokines and chemokines play a role in the pathogenesis of DEE and why expanding our knowledge about the role of neuroinflammation in DEE may be crucial to develop new and effective targeted therapeutic strategies to prevent seizure recurrence and developmental regression.

Original languageEnglish
Article number106588
JournalEpilepsy Research
Volume172
DOIs
Publication statusPublished - May 2021

Keywords

  • Chemokine
  • Cytokine
  • Epilepsy
  • Neuroinflammation
  • Steroid
  • West syndrome

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'The role of inflammatory mediators in epilepsy: Focus on developmental and epileptic encephalopathies and therapeutic implications'. Together they form a unique fingerprint.

Cite this